keyword
https://read.qxmd.com/read/38687953/erratum-adjuvant-abemaciclib-plus-endocrine-therapy-for-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-high-risk-early-breast-cancer-results-from-a-preplanned-monarche-overall-survival-interim-analysis-including-5-year-efficacy
#1
https://read.qxmd.com/read/38687506/incretin-based-weight-loss-pharmacotherapy-can-resistance-exercise-optimize-changes-in-body-composition
#2
JOURNAL ARTICLE
João Carlos Locatelli, Juliene Gonçalves Costa, Andrew Haynes, Louise H Naylor, P Gerry Fegan, Bu B Yeap, Daniel J Green
This narrative review highlights the degree to which new antiobesity medications based on gut-derived nutrient-stimulated hormones (incretins) cause loss of lean mass, and the importance of resistance exercise to preserve muscle. Glucagon-like peptide 1 receptor agonists (GLP-1RA) induce substantial weight loss in randomized trials, effects that may be enhanced in combination with glucose-dependent insulinotropic polypeptide (GIP) receptor agonists. Liraglutide and semaglutide (GLP-1RA), tirzepatide (GLP-1 and GIP receptor dual agonist), and retatrutide (GLP-1, GIP, and glucagon receptor triple agonist) are peptides with incretin agonist activity that induce ∼15-24% weight loss in adults with overweight and obesity, alongside beneficial impacts on blood pressure, cholesterol, blood glucose, and insulin...
April 30, 2024: Diabetes Care
https://read.qxmd.com/read/38687430/risk-of-first-recurrence-after-treatment-in-a-population-based-cohort-of-young-women-with-breast-cancer
#3
JOURNAL ARTICLE
Robin Schaffar, Simone Benhamou, Pierre O Chappuis, Elisabetta Rapiti
PURPOSE: Breast cancer (BC) in women under 45 is rare yet often aggressive. We aim to analyze loco-regional recurrences (LR), distant recurrences (DR), second breast cancers, and mortality in young BC patients. METHODS: We enrolled 776 women with non-metastatic BC ≤45 years diagnosed from 1970 to 2012. Variables included age, family history, tumor stage/grade, and treatment. We used multivariate Cox regression and competing risk models. RESULTS: Among the participants, 37...
April 30, 2024: Breast Cancer Research and Treatment
https://read.qxmd.com/read/38687407/relationship-between-her2-low-status-and-efficacy-of-cdk4-6-inhibitors-in-advanced-breast-cancer-a-real-world-study
#4
JOURNAL ARTICLE
T Önder, Ö Ateş, I Öner, C Karaçin
AIMS AND OBJECTIVES: Human epidermal growth factor receptor 2 (HER2)-low breast cancer (BC) is a new entity considered a biologically distinct subtype from HER2-zero BC. However, the importance of HER2 low expression on the activity of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) remains unclear. METHODS/MATERIALS: We conducted a single-center retrospective study including hormone receptor-positive (HR +) /HER2- metastatic BC (mBC) patients treated with CDK4/6i plus endocrine treatment (ET) as first-line therapy...
April 30, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38686896/an-overlooked-disease-minimal-autonomous-cortisol-secretion-macs-a-narrative-review
#5
JOURNAL ARTICLE
Stephanie Farah, Leah Nasr, Jocelyne Eid Fares
BACKGROUND: A far more common disease than Cushing's syndrome is subclinical hypercortisolism or mild autonomous cortisol secretion (MACS), with an overall prevalence of 0.2-2%. OBJECTIVE: This review aims to shed light on the prevalence, screening and diagnostic criteria, comorbidities, and management of Mild Autonomous Cortisol Secretion (MACS). METHODS: Studies eligible targeted MACS regarding prevalence, screening, comorbidities, management, and clinical outcome...
February 16, 2024: Endocrine, Metabolic & Immune Disorders Drug Targets
https://read.qxmd.com/read/38686826/rapidly-expanding-gender-affirming-care-based-on-consensus-instead-of-evidence-justifies-rigorous-governance-and-transparency
#6
JOURNAL ARTICLE
Andrew James Amos
OBJECTIVE: Public services offering gender-affirming care to minors have rapidly expanded across Australia. Despite limited evidence of safety and efficacy, no public information about these services is routinely available. Data from freedom of information requests sent to Australian public gender services for minors is summarised. Gender service numbers increased rapidly in Queensland (2017:190 - 2022:922) and in Victoria (2019:472 - 2023:1290). Limited transparency prevented strong confidence in the number of patients receiving hormone therapy...
April 30, 2024: Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists
https://read.qxmd.com/read/38686660/why-does-hormonal-contraception-and-menopausal-hormonal-treatment-have-such-a-small-effect-on-breast-cancer-risk
#7
JOURNAL ARTICLE
John A Eden
Oestrogen is considered by many to be a major cause of breast cancer, and yet hormonal contraception and menopausal hormonal therapy have a paradoxically small effect on breast cancer risk. Also, in the oestrogen-only arm of the Women's Health Initiative, subjects given oestrogen had a reduced risk of breast cancer compared to controls. Initiation of breast cancer likely begins early in life, in the long-lived ER- PR- breast stem cell. The main mitogen of ER+ PR+ breast cancers is oestrogen derived from local breast fat and the tumour itself, rather than circulating oestrogens...
April 30, 2024: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/38686449/genetic-determined-iron-starvation-signature-in-friedreich-s-ataxia
#8
JOURNAL ARTICLE
Manuel Grander, David Haschka, Elisabetta Indelicato, Christian Kremser, Matthias Amprosi, Wolfgang Nachbauer, Benjamin Henninger, Ambra Stefani, Birgit Högl, Christine Fischer, Markus Seifert, Stefan Kiechl, Günter Weiss, Sylvia Boesch
BACKGROUND: Early studies in cellular models suggested an iron accumulation in Friedreich's ataxia (FA), yet findings from patients are lacking. OBJECTIVES: The objective is to characterize systemic iron metabolism, body iron storages, and intracellular iron regulation in FA patients. METHODS: In FA patients and matched healthy controls, we assessed serum iron parameters, regulatory hormones as well as the expression of regulatory proteins and iron distribution in peripheral blood mononuclear cells (PBMCs)...
April 30, 2024: Movement Disorders: Official Journal of the Movement Disorder Society
https://read.qxmd.com/read/38686274/myxedema-psychosis-diagnostic-challenges-and-management-strategies-in-hypothyroidism-induced-psychosis
#9
Moujib Omri, Mohamed Ferhi, Nina Lentz, Marizia Oliveira Galvao, Oliver Hamm
Myxedema psychosis (MP), a rare psychiatric manifestation of hypothyroidism, presents significant diagnostic and therapeutic challenges. This case report details the presentation, diagnosis, and successful management of a 60-year-old woman with MP, who was initially admitted to the psychiatric department for new-onset psychosis following the cessation of hormone replacement therapy after a subtotal thyroidectomy performed 20 years prior. Despite the rarity of psychosis as an initial presentation of hypothyroidism, this case underscores the critical importance of considering endocrine disorders in the differential diagnosis of unexplained psychotic symptoms...
March 2024: Curēus
https://read.qxmd.com/read/38685847/neoadjuvant-chemotherapy-in-patients-with-her2-negative-breast-cancer-a-report-from-clinical-breast-cancer-registry-of-iran
#10
JOURNAL ARTICLE
Kamran Roudini, Mehrzad Mirzania, Tahereh Yavari, Monireh Sadat Seyyedsalehi, Azin Nahvijou, Jayran Zebardast, Mina Saadat, Ahmad Khajeh-Mehrizi
BACKGROUND: Neoadjuvant chemotherapy (NCT) has become an increasingly popular approach in management of breast cancer (BC). This study was conducted to evaluate the pathologic response and 36-month recurrence and survival rates of patients with human epidermal growth factor receptor 2 (HER2)-negative BC treated with different NCT regimens. METHODS: A total of 163 female patients with HER2-negative BC who received NCT during 2017-2020 were identified from the Clinical Breast Cancer Registry of Iran and entered the study...
April 1, 2024: Archives of Iranian Medicine
https://read.qxmd.com/read/38684697/epigenetic-mechanisms-regulate-sex-differences-in-cardiac-reparative-functions-of-bone-marrow-progenitor-cells
#11
JOURNAL ARTICLE
Charan Thej, Rajika Roy, Zhongjian Cheng, Venkata Naga Srikanth Garikipati, May M Truongcao, Darukeshwara Joladarashi, Vandana Mallaredy, Maria Cimini, Carolina Gonzalez, Ajit Magadum, Jayashri Ghosh, Cindy Benedict, Walter J Koch, Raj Kishore
Historically, a lower incidence of cardiovascular diseases (CVD) and related deaths in women as compared with men of the same age has been attributed to female sex hormones, particularly estrogen and its receptors. Autologous bone marrow stem cell (BMSC) clinical trials for cardiac cell therapy overwhelmingly included male patients. However, meta-analysis data from these trials suggest a better functional outcome in postmenopausal women as compared with aged-matched men. Mechanisms governing sex-specific cardiac reparative activity in BMSCs, with and without the influence of sex hormones, remain unexplored...
April 29, 2024: NPJ Regenerative Medicine
https://read.qxmd.com/read/38683596/aspirin-vs-placebo-as-adjuvant-therapy-for-breast-cancer-the-alliance-a011502-randomized-trial
#12
JOURNAL ARTICLE
Wendy Y Chen, Karla V Ballman, Ann H Partridge, Olwen M Hahn, Frederick M Briccetti, William J Irvin, Banu Symington, Kala Visvanathan, Paula R Pohlmann, Thomas H Openshaw, Anna Weiss, Eric P Winer, Lisa A Carey, Michelle D Holmes
IMPORTANCE: Observational studies of survivors of breast cancer and prospective trials of aspirin for cardiovascular disease suggest improved breast cancer survival among aspirin users, but prospective studies of aspirin to prevent breast cancer recurrence are lacking. OBJECTIVE: To determine whether aspirin decreases the risk of invasive cancer events among survivors of breast cancer. DESIGN, SETTING, AND PARTICIPANTS: A011502, a phase 3, randomized, placebo-controlled, double-blind trial conducted in the United States and Canada with 3020 participants who had high-risk nonmetastatic breast cancer, enrolled participants from 534 sites from January 6, 2017, through December 4, 2020, with follow-up to March 4, 2023...
April 29, 2024: JAMA
https://read.qxmd.com/read/38683294/the-effect-of-thiazolidinediones-in-polycystic-ovary-syndrome-a-systematic-review-and-meta-analysis-of-randomised-controlled-trials
#13
REVIEW
Mohammed A Abdalla, Najeeb Shah, Harshal Deshmukh, Amirhossein Sahebkar, Linda Östlundh, Rami H Al-Rifai, Stephen L Atkin, Thozhukat Sathyapalan
INTRODUCTION: Polycystic ovary syndrome (PCOS) is a complex endocrine condition affecting women of reproductive age. It is characterised by insulin resistance and is a risk for type 2 diabetes mellitus (T2DM). The aim of this study was to review the literature on the effect of pioglitazone and rosiglitazone in women with PCOS. METHODS: We searched PubMed, MEDLINE, Scopus, Embase, Cochrane Library and the Web of Science in April 2020 and updated in March 2023...
April 29, 2024: Advances in Therapy
https://read.qxmd.com/read/38683021/delayed-puberty-and-management-of-treatment
#14
JOURNAL ARTICLE
Ayhan Abacı, Özge Besci
Delayed puberty is defined as the lack of development of secondary sex characteristics in childhood. Based on a review of the literature, delayed puberty can be divided into three main categories: (i) hypergonadotropic hypogonadism (congenital and acquired), (ii) permanent hypogonadotropic hypogonadism (congenital and acquired), and (iii) transient hypogonadotropic hypogonadism [constitutional delay of growth and puberty (CDGP) and functional hypogonadotropic hypogonadism (FHH)]. CDGP is the most common cause of hypogonadism in both males and females, accounting for 60% and 30% respectively...
April 29, 2024: Journal of Clinical Research in Pediatric Endocrinology
https://read.qxmd.com/read/38682851/refractory-hypothyroidism
#15
JOURNAL ARTICLE
Y Y Lai, S C Thambiah, N Mohamed Mokhtar, I N Samsudin
INTRODUCTION: Persistently elevated thyroid stimulating hormone (TSH) despite levothyroxine (LT4) treatment that exceeds the standard weight-adjusted dose is a common clinical presentation. This may lead to additional testing for LT4 malabsorption or poor LT4 adherence, the latter of which is challenging to confirm because it is predicated on accurate patient accountability. CASE REPORT: A 35-year-old lady, post-radioactive iodine therapy for Graves' disease remained euthyroid for a year on oral LT4...
April 2024: Malaysian Journal of Pathology
https://read.qxmd.com/read/38682022/role-and-limitation-of-cell-therapy-in-treating-neurological-diseases
#16
REVIEW
Yu-Qi Li, Peng-Fei Li, Qian Tao, Issam J A Abuqeis, Yan-Bin Xiyang
The central role of the brain in governing systemic functions within human physiology underscores its paramount significance as the focal point of physiological regulation. The brain, a highly sophisticated organ, orchestrates a diverse array of physiological processes encompassing motor control, sensory perception, cognition, emotion, and the regulation of vital functions, such as heartbeat, respiration, and hormonal equilibrium. A notable attribute of neurological diseases manifests as the depletion of neurons and the occurrence of tissue necrosis subsequent to injury...
2024: Ibrain
https://read.qxmd.com/read/38681984/combination-treatment-of-inflammatory-bowel-disease-present-status-and-future-perspectives
#17
REVIEW
John K Triantafillidis, Constantinos G Zografos, Manousos M Konstadoulakis, Apostolos E Papalois
The treatment of patients with inflammatory bowel disease (IBD), especially those with severe or refractory disease, represents an important challenge for the clinical gastroenterologist. It seems to be no exaggeration to say that in these patients, not only the scientific background of the gastroenterologist is tested, but also the abundance of "gifts" that he should possess (insight, intuition, determination, ability to take initiative, etc. ) for the successful outcome of the treatment. In daily clinical practice, depending on the severity of the attack, IBD is treated with one or a combination of two or more pharmaceutical agents...
April 21, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38681523/single-cocaine-exposure-attenuates-the-intrinsic-excitability-of-crh-neurons-in-the-ventral-bnst-via-sigma-1-receptors
#18
JOURNAL ARTICLE
Jintao Wu, Yue Zhao
The ventral bed nucleus of the stria terminalis (vBNST) plays a key role in cocaine addiction, especially relapse. However, the direct effects of cocaine on corticotropin-releasing hormone (CRH) neurons in the vBNST remain unclear. Here, we identify that cocaine exposure can remarkably attenuate the intrinsic excitability of CRH neurons in the vBNST in vitro . Accumulating studies reveal the crucial role of Sigma-1 receptors (Sig-1Rs) in modulating cocaine addiction. However, to the authors' best knowledge no investigations have explored the role of Sig-1Rs in the vBNST, let alone CRH neurons...
January 1, 2024: Translational Neuroscience
https://read.qxmd.com/read/38681284/a-comprehensive-approach-correlating-ultrasound-imaging-with-endometrial-histopathological-analysis-in-perimenopausal-women-with-heavy-menstrual%C3%A2-bleeding
#19
JOURNAL ARTICLE
Vidhya Selvam, Pooja Lakshminarayanan
INTRODUCTION: Abnormal uterine bleeding (AUB) is a common troublesome symptom in the perimenopausal age group. The most common type of AUB in this age group is heavy menstrual bleeding. There is a risk of endometrial carcinoma and atypical endometrial hyperplasia in women with AUB in the age group of 40-50 years. Hence early evaluation is of paramount importance in managing women with perimenopausal heavy menstrual bleeding. The current study was undertaken to study the correlation between ultrasound findings and various benign and malignant endometrial histologies in perimenopausal women with heavy menstrual bleeding...
March 2024: Curēus
https://read.qxmd.com/read/38681054/igm-kappa-proliferative-glomerulonephritis-with-monoclonal-immunoglobulin-deposition-complicated-with-nocardiosis-dermatitis-a-case-report-and-review-of-literature
#20
Kebao Chen, Yue Wang, Jinyu Yu, Xueyao Wang, Zhonggao Xu, Yanbo Li, Weixia Sun
RATIONALE: Monoclonal gammopathy of renal significance (MGRS) represents a group of disorders caused by monoclonal immunoglobulin (M protein) secreted by B cells or plasma cells. Proliferative glomerulonephritis with monoclonal immunoglobulin deposition (PGNMID) is a glomerular disease and a form of MGRS. Here, we presented a rare case of a patient with IgM kappa PGNMID complicated with nocardiosis dermatitis. PATIENT CONCERNS AND DIAGNOSES: A 56-year-old man was admitted to the hospital because of cutaneous purpura and proteinuria...
2024: Frontiers in Medicine
keyword
keyword
12260
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.